Welcome to our weekly roundup of CBD and hemp-related legal and regulatory news:
CBD
Physicians remain reluctant to prescribe CBD for epilepsy
While the FDA has approved cannabis-derived prescription drug, Epidiolex, for three rare seizure disorders, not much has changed
Continue Reading CBD and Hemp Legal and Regulatory Roundup – July 15, 2022